Progressing Precision Healthcare 12 November 2024
Professor Claudia Langenberg, Director of the Precision Healthcare University Research Institute (PHURI) at Queen Mary University of London, discusses the future of precision medicine. With an impressive background as Professor of Computational Medicine at the Berlin Institute of Health at Charité Universitätsmedizin, Germany, and former Programme Leader at the MRC Epidemiology Unit at the University of Cambridge, Professor Langenberg brings invaluable insight into the cutting-edge developments shaping this rapidly evolving field.
In this interview, we explore the most significant trends in precision medicine, the challenges of deploying these approaches at scale, and the role of data-driven techniques and artificial intelligence. Professor Langenberg shares her views on the UK’s position as a global leader in precision medicine, highlighting the unique opportunities presented by North-East London, including the Barts Health Data Platform
New research networks will tackle antimicrobial resistance 1 October 2024
Professor Mark Bradely and Dr Sesha Venkateswaran have been awarded a UK Research and Innovation grant to tackle antimicrobial resistant infections.
Blood proteins predict the risk of developing more than 60 diseases 22 July 2024
Protein ‘signatures’, which can be obtained via a blood sample, can be used to predict the onset of 67 diseases including multiple myeloma, non-Hodgkin lymphoma, motor neurone disease, pulmonary fibrosis, and dilated cardiomyopathy. Using protein information to predict the onset of diseases could help with timely diagnosis, early initiation of treatment and improved patient outcomes.
Reporting guidelines for precision medicine research of clinical relevance: the BePRECISE checklist 19 July 2024
The inaugural reporting guidelines for precision medicine research have been published in Nature Medicine
PHURI's Director elected to membership of EMBO 9 July 2024
Queen Mary University of London congratulates Professor Claudia Langenberg on her recent election to the European Molecular Biology Organization (EMBO) Membership.
Complex patterns of multimorbidity associated with severe COVID-19 and long COVID 8 July 2024
Early evidence that patients with (multiple) pre-existing diseases are at highest risk for severe COVID-19 has been instrumental in the pandemic to allocate critical care resources and later vaccination schemes. However, systematic studies exploring the breadth of medical diagnoses are scarce but may help to understand severe COVID-19 among patients at supposedly low risk.
The genetic causes of Raynaud’s phenomenon. 21 June 2024
Researchers at Queen Mary University of London’s Precision Healthcare Research Institute (PHURI) and the Berlin Institute of Health (BIH) at Charité – Universitätsmedizin Berlin have identified the genetic causes of Raynaud’s phenomenon.
Fasting for three days can trigger weight loss but seven is too much 4 March 2024
Scientists at Queen Mary University of London monitored 12 healthy volunteers taking part in a week-long water fast and tracked changes in the levels of 3,000 proteins in their blood.
Performance of polygenic risk scores in screening, prediction, and risk stratification. 31 December 2023
Performance of polygenic risk scores in screening, prediction, and risk stratification: secondary analysis of data in the Polygenic Score Catalog.